Efficacy and Safety of Cilostazol for the Indication of CSPS
NCT00216749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650
Last updated 2009-12-17
Summary
This is a multicenter, open-label, prospective study of cilostazol use for prevention of recurrence in patients with cerebral infarction.
Conditions
- Cerebral Infarction
Sponsors & Collaborators
-
Korea Otsuka Pharmaceutical Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Bo Youn Seo · Korea Otsuka Pharmaceutical Co., Ltd.
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
- Primary Completion
- 2007-10-31
- Completion
- 2007-10-31
Countries
- South Korea
Study Locations
More Related Trials
-
Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage
NCT06504576 ·Status: RECRUITING ·Phase: PHASE2
-
Synergistic Effect of Combination Therapy With Cilostazol and Probucol on Plaque Stabilization and Lesion Regression: Serial Intravascular Ultrasound and Virtual Histology Study(SECURE Study)
NCT01031667 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke
NCT00202020 ·Status: COMPLETED ·Phase: PHASE3
-
PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study
NCT02483169 ·Status: UNKNOWN ·Phase: PHASE4
-
Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
NCT00130039 ·Status: COMPLETED ·Phase: PHASE4
-
Pletaal SR Post Marketing Observational Study
NCT01782833 ·Status: COMPLETED
-
Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol
NCT07180472 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy Study of Cilostazol and Aspirin on Cerebral Small Vessel Disease
NCT01932203 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Cilostazol Compared to Aspirin on Endothelial Function in Acute Cerebral Ischemia Patients
NCT03116269 ·Status: COMPLETED ·Phase: PHASE4
-
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
NCT01013532 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
NCT00823875 ·Status: COMPLETED ·Phase: PHASE4
-
Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
NCT06530537 ·Status: RECRUITING ·Phase: PHASE3
-
The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis
NCT06757764 ·Status: RECRUITING ·Phase: PHASE4
-
Cilostazol and Aspirin in Stroke and TIA
NCT06522113 ·Status: COMPLETED ·Phase: PHASE4
-
Cilostazol for Prevention of Recurrent Stroke Trial
NCT07174414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
CiLostAzol for pReventIon of Recurrent sTroke in Africa
NCT06919835 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension
NCT00325637 ·Status: COMPLETED ·Phase: PHASE3
-
Cilostazol Verse Asprin for Vascular Dementia in Poststroke Patients With White Matter Lesions
NCT00847860 ·Status: COMPLETED ·Phase: PHASE4
-
The Safety and Efficacy of Cilostazol in Ischemic Stroke Patients With Peripheral Arterial Disease (SPAD Study)
NCT01188824 ·Status: COMPLETED ·Phase: PHASE4
-
Cilostazol Stroke Prevention Study for Antiplatelet Combination
NCT01995370 ·Status: COMPLETED ·Phase: PHASE4
-
Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
NCT04148105 ·Status: TERMINATED ·Phase: PHASE4
-
Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
NCT06242145 ·Status: COMPLETED ·Phase: PHASE3
-
Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage
NCT07144956 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Clopidogrel Versus Cilostazol in Ischemic Stroke
NCT06242132 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety
NCT01142284 ·Status: COMPLETED ·Phase: PHASE2